bisoprolol has been researched along with Asthma in 8 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim To compare efficacy and safety of treatments with the calcium antagonist (CA) verapamil, the cardioselective β-blocker (BB) bisoprolol, and a combination therapy with bisoprolol and amlodipine in patients with stable angina (SA) with concurrent mild and moderate, persistent bronchial asthma (BA)." | 9.51 | The possibilities of using beta-blocker bisoprolol in patients with stable angina with concomitant bronchial asthma. ( Grigorieva, NY; Ilushina, TP; Kolosova, KS, 2022) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 9.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "In a double blind, placebo-controlled study the ventilatory effects of the beta 1-selective receptor blockers bisoprolol (EMD 33512) and metoprolol and their interactions with the beta 2-adrenoceptor agonist terbutaline were investigated in 8 asthmatic patients." | 9.05 | Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1984) |
| "to compare the antianginal and pulse slowing effects, the impact on the ectopic myocardial activity as well as the safety of the treatment with beta - adrenoblocker bisoprolol, calcium antagonist verapamil and the combination of bisoprolol with amlodipine in patients with stable angina (SA) and bronchial asthma (BA)." | 7.91 | [Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma]. ( Grigorieva, NY; Ilyushina, TP; Yashina, EM, 2019) |
| "The respiratory tolerance of the beta 1-adrenoceptor-selective blockers bisoprolol and metoprolol was investigated in eight male asthmatic patients." | 7.67 | Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1986) |
| "Aim To compare efficacy and safety of treatments with the calcium antagonist (CA) verapamil, the cardioselective β-blocker (BB) bisoprolol, and a combination therapy with bisoprolol and amlodipine in patients with stable angina (SA) with concurrent mild and moderate, persistent bronchial asthma (BA)." | 5.51 | The possibilities of using beta-blocker bisoprolol in patients with stable angina with concomitant bronchial asthma. ( Grigorieva, NY; Ilushina, TP; Kolosova, KS, 2022) |
| "The cardioselectivity and hypotensive properties of the beta 1-specific beta-blocker bisoprolol were investigated using a single-dose comparison of 10 and 20 mg bisoprolol, 100 mg atenolol, and placebo in 12 hypertensive asthmatic patients." | 5.06 | The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics. ( Chatterjee, SS, 1986) |
| "In a double blind, placebo-controlled study the ventilatory effects of the beta 1-selective receptor blockers bisoprolol (EMD 33512) and metoprolol and their interactions with the beta 2-adrenoceptor agonist terbutaline were investigated in 8 asthmatic patients." | 5.05 | Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1984) |
| "to compare the antianginal and pulse slowing effects, the impact on the ectopic myocardial activity as well as the safety of the treatment with beta - adrenoblocker bisoprolol, calcium antagonist verapamil and the combination of bisoprolol with amlodipine in patients with stable angina (SA) and bronchial asthma (BA)." | 3.91 | [Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma]. ( Grigorieva, NY; Ilyushina, TP; Yashina, EM, 2019) |
| "The respiratory tolerance of the beta 1-adrenoceptor-selective blockers bisoprolol and metoprolol was investigated in eight male asthmatic patients." | 3.67 | Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigorieva, NY | 2 |
| Ilushina, TP | 1 |
| Kolosova, KS | 1 |
| Ilyushina, TP | 1 |
| Yashina, EM | 1 |
| Bennett, MR | 1 |
| Chang, CL | 1 |
| Tuffery, C | 1 |
| Hopping, S | 1 |
| Hancox, RJ | 1 |
| Erokhina, IL | 1 |
| Voronchikhin, PA | 1 |
| Okovityĭ, SV | 1 |
| Emel'ianova, OI | 1 |
| Lammers, JW | 2 |
| Folgering, HT | 2 |
| van Herwaarden, CL | 2 |
| Pujet, JC | 1 |
| Dubreuil, C | 1 |
| Fleury, B | 1 |
| Provendier, O | 1 |
| Abella, ML | 1 |
| Chatterjee, SS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for bisoprolol and Asthma
| Article | Year |
|---|---|
The possibilities of using beta-blocker bisoprolol in patients with stable angina with concomitant bronchial asthma.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Asthma; Bisoprolol; Humans; Prospective Studies | 2022 |
The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bisoprolol; Bronchod | 2021 |
Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bisoprolol; Blood Pressure; Forced Expiratory Volume; He | 1984 |
Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Asthma; Bisoprolol; Bronchoconstriction; Celiprolol; Double-Blin | 1992 |
The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
Topics: Adrenergic beta-Antagonists; Aged; Albuterol; Asthma; Bisoprolol; Blood Pressure; Bronchial Provocat | 1986 |
3 other studies available for bisoprolol and Asthma
| Article | Year |
|---|---|
[Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma].
Topics: Adrenergic beta-Antagonists; Amlodipine; Asthma; Bisoprolol; Coronary Artery Disease; Humans | 2019 |
[Reaction of population of pulmonary mast cells in rat bronchial asthma under the effect of β-adrenoreceptor antagonists].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alcian Blue; Animals; Anti-Asthmat | 2013 |
Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Asthma; Bisoprolol; Bronchial Spasm; Humans; Male; Metoprolol; Peak Exp | 1986 |